Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • About
    • General information
    • Staff
    • Editorial board
    • Open access
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ Open
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN
CMAJ Open

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • About
    • General information
    • Staff
    • Editorial board
    • Open access
    • Contact
  • RSS feeds
Getting new auth cookie, if you see this message a lot, tell someone!
Research
Open Access

Cost-effectiveness modelling of birth and infant dose vaccination against hepatitis B virus in Ontario from 2020 to 2050

Mia J. Biondi, Chris Estes, Devin Razavi-Shearer, Kanwar Sahdra, Nechama Lipton, Hemant Shah, Camelia Capraru, Harry L.A. Janssen, Homie Razavi and Jordan J. Feld
January 10, 2023 11 (1) E24-E32; DOI: https://doi.org/10.9778/cmajo.20210284
Mia J. Biondi
Viral Hepatitis Care Network (VIRCAN) Study Group (Biondi, Sahdra, Lipton, Shah, Capraru, Janssen, Feld), Toronto Centre for Liver Disease; Institute of Medical Sciences (Feld), University of Toronto; School of Nursing (Biondi), York University, Toronto, Ont.; Arthur Labatt Family School of Nursing (Biondi), Western University, London, Ont.; Center for Disease Analysis Foundation (Estes, Razavi-Shearer, Razavi), Lafayette, Colo.
PhD NP-PHC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chris Estes
Viral Hepatitis Care Network (VIRCAN) Study Group (Biondi, Sahdra, Lipton, Shah, Capraru, Janssen, Feld), Toronto Centre for Liver Disease; Institute of Medical Sciences (Feld), University of Toronto; School of Nursing (Biondi), York University, Toronto, Ont.; Arthur Labatt Family School of Nursing (Biondi), Western University, London, Ont.; Center for Disease Analysis Foundation (Estes, Razavi-Shearer, Razavi), Lafayette, Colo.
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Devin Razavi-Shearer
Viral Hepatitis Care Network (VIRCAN) Study Group (Biondi, Sahdra, Lipton, Shah, Capraru, Janssen, Feld), Toronto Centre for Liver Disease; Institute of Medical Sciences (Feld), University of Toronto; School of Nursing (Biondi), York University, Toronto, Ont.; Arthur Labatt Family School of Nursing (Biondi), Western University, London, Ont.; Center for Disease Analysis Foundation (Estes, Razavi-Shearer, Razavi), Lafayette, Colo.
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kanwar Sahdra
Viral Hepatitis Care Network (VIRCAN) Study Group (Biondi, Sahdra, Lipton, Shah, Capraru, Janssen, Feld), Toronto Centre for Liver Disease; Institute of Medical Sciences (Feld), University of Toronto; School of Nursing (Biondi), York University, Toronto, Ont.; Arthur Labatt Family School of Nursing (Biondi), Western University, London, Ont.; Center for Disease Analysis Foundation (Estes, Razavi-Shearer, Razavi), Lafayette, Colo.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nechama Lipton
Viral Hepatitis Care Network (VIRCAN) Study Group (Biondi, Sahdra, Lipton, Shah, Capraru, Janssen, Feld), Toronto Centre for Liver Disease; Institute of Medical Sciences (Feld), University of Toronto; School of Nursing (Biondi), York University, Toronto, Ont.; Arthur Labatt Family School of Nursing (Biondi), Western University, London, Ont.; Center for Disease Analysis Foundation (Estes, Razavi-Shearer, Razavi), Lafayette, Colo.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hemant Shah
Viral Hepatitis Care Network (VIRCAN) Study Group (Biondi, Sahdra, Lipton, Shah, Capraru, Janssen, Feld), Toronto Centre for Liver Disease; Institute of Medical Sciences (Feld), University of Toronto; School of Nursing (Biondi), York University, Toronto, Ont.; Arthur Labatt Family School of Nursing (Biondi), Western University, London, Ont.; Center for Disease Analysis Foundation (Estes, Razavi-Shearer, Razavi), Lafayette, Colo.
MD MScCH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Camelia Capraru
Viral Hepatitis Care Network (VIRCAN) Study Group (Biondi, Sahdra, Lipton, Shah, Capraru, Janssen, Feld), Toronto Centre for Liver Disease; Institute of Medical Sciences (Feld), University of Toronto; School of Nursing (Biondi), York University, Toronto, Ont.; Arthur Labatt Family School of Nursing (Biondi), Western University, London, Ont.; Center for Disease Analysis Foundation (Estes, Razavi-Shearer, Razavi), Lafayette, Colo.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harry L.A. Janssen
Viral Hepatitis Care Network (VIRCAN) Study Group (Biondi, Sahdra, Lipton, Shah, Capraru, Janssen, Feld), Toronto Centre for Liver Disease; Institute of Medical Sciences (Feld), University of Toronto; School of Nursing (Biondi), York University, Toronto, Ont.; Arthur Labatt Family School of Nursing (Biondi), Western University, London, Ont.; Center for Disease Analysis Foundation (Estes, Razavi-Shearer, Razavi), Lafayette, Colo.
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Homie Razavi
Viral Hepatitis Care Network (VIRCAN) Study Group (Biondi, Sahdra, Lipton, Shah, Capraru, Janssen, Feld), Toronto Centre for Liver Disease; Institute of Medical Sciences (Feld), University of Toronto; School of Nursing (Biondi), York University, Toronto, Ont.; Arthur Labatt Family School of Nursing (Biondi), Western University, London, Ont.; Center for Disease Analysis Foundation (Estes, Razavi-Shearer, Razavi), Lafayette, Colo.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jordan J. Feld
Viral Hepatitis Care Network (VIRCAN) Study Group (Biondi, Sahdra, Lipton, Shah, Capraru, Janssen, Feld), Toronto Centre for Liver Disease; Institute of Medical Sciences (Feld), University of Toronto; School of Nursing (Biondi), York University, Toronto, Ont.; Arthur Labatt Family School of Nursing (Biondi), Western University, London, Ont.; Center for Disease Analysis Foundation (Estes, Razavi-Shearer, Razavi), Lafayette, Colo.
MD MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Jump to comment:

No Responses have been published for this article.
PreviousNext
Back to top

In this issue

CMAJ Open: 11 (1)
Vol. 11, Issue 1
1 Jan 2023
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ Open.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cost-effectiveness modelling of birth and infant dose vaccination against hepatitis B virus in Ontario from 2020 to 2050
(Your Name) has sent you a message from CMAJ Open
(Your Name) thought you would like to see the CMAJ Open web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cost-effectiveness modelling of birth and infant dose vaccination against hepatitis B virus in Ontario from 2020 to 2050
Mia J. Biondi, Chris Estes, Devin Razavi-Shearer, Kanwar Sahdra, Nechama Lipton, Hemant Shah, Camelia Capraru, Harry L.A. Janssen, Homie Razavi, Jordan J. Feld
Jan 2023, 11 (1) E24-E32; DOI: 10.9778/cmajo.20210284

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cost-effectiveness modelling of birth and infant dose vaccination against hepatitis B virus in Ontario from 2020 to 2050
Mia J. Biondi, Chris Estes, Devin Razavi-Shearer, Kanwar Sahdra, Nechama Lipton, Hemant Shah, Camelia Capraru, Harry L.A. Janssen, Homie Razavi, Jordan J. Feld
Jan 2023, 11 (1) E24-E32; DOI: 10.9778/cmajo.20210284
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Collections

  • Clinical
    • Community Medicine
    • Public Health
      • Vaccination
      • Other public health
    • Pediatrics
      • Other pediatrics
    • Infectious Diseases
      • Other infectious diseases
    • Gastroenterology
      • Liver (including hepatitis and cirrhosis)
    • Immunology
      • Drugs: immunological products and vaccines
  • Nonclinical
    • Health Policy
      • Other health policy

Content

  • Current issue
  • Past issues
  • Collections

About

  • General Information
  • Staff
  • Editorial Board
  • Advisory Panel
  • Contact Us
  • Reprints
  • Copyright and Permissions
CMAJ Group

Copyright 2025, CMA Impact Inc. or its licensors. All rights reserved. ISSN 2291-0026

All editorial matter in CMAJ OPEN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].

CMA Civility, Accessibility, Privacy

 

 

Powered by HighWire